Charles River Laboratories International Inc. (CRL) is priced at $241.08 after the most recent trading session. At the very opening of the session, the stock price was $242.15 and reached a high price of $244.22, prior to closing the session it reached the value of $242.13. The stock touched a low price of $240.65.Recently in News on November 14, 2022, Charles River Laboratories to Present at November Investor Conferences. Charles River Laboratories International, Inc. (NYSE: CRL) announced today that it will present at two upcoming investor conferences, including:. You can read further details here
Charles River Laboratories International Inc. had a pretty Dodgy run when it comes to the market performance. The 1-year high price for the company’s stock is recorded $376.78 on 01/03/22, with the lowest value was $181.36 for the same time period, recorded on 09/27/22.
Charles River Laboratories International Inc. (CRL) full year performance was -34.84%
Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, Charles River Laboratories International Inc. shares are logging -37.40% during the 52-week period from high price, and 32.93% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $181.36 and $385.11.
The company’s shares, operating in the sector of Healthcare managed to top a trading volume set approximately around 324056 for the day, which was evidently lower, when compared to the average daily volumes of the shares.
When it comes to the year-to-date metrics, the Charles River Laboratories International Inc. (CRL) recorded performance in the market was -36.02%, having the revenues showcasing 12.73% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 12.03B, as it employees total of 18600 workers.
Analysts verdict on Charles River Laboratories International Inc. (CRL)
During the last month, 0 analysts gave the Charles River Laboratories International Inc. a BUY rating, 0 of the polled analysts branded the stock as an OVERWEIGHT, 0 analysts were recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 of the polled analysts provided SELL rating.
According to the data provided on Barchart.com, the moving average of the company in the 100-day period was set at 216.54, with a change in the price was noted +18.36. In a similar fashion, Charles River Laboratories International Inc. posted a movement of +8.24% for the period of last 100 days, recording 575,699 in trading volumes.
Total Debt to Equity Ratio (D/E) can also provide valuable insight into the company’s financial health and market status. The debt to equity ratio can be calculated by dividing the present total liabilities of a company by shareholders’ equity. Debt to Equity thus makes a valuable metrics that describes the debt, company is using in order to support assets, correlating with the value of shareholders’ equity The total Debt to Equity ratio for CRL is recording 1.12 at the time of this writing. In addition, long term Debt to Equity ratio is set at 1.12.
Charles River Laboratories International Inc. (CRL): Technical Analysis
Raw Stochastic average of Charles River Laboratories International Inc. in the period of last 50 days is set at 84.07%. The result represents improvement in oppose to Raw Stochastic average for the period of the last 20 days, recording 76.88%. In the last 20 days, the company’s Stochastic %K was 77.44% and its Stochastic %D was recorded 77.89%.
Let’s take a glance in the erstwhile performances of Charles River Laboratories International Inc., multiple moving trends are noted. Year-to-date Price performance of the company’s stock appears to be encouraging, given the fact the metric is recording -36.02%. Additionally, trading for the stock in the period of the last six months notably improved by 7.88%, alongside a downfall of -34.84% for the period of the last 12 months. The shares increased approximately by 0.71% in the 7-day charts and went down by 10.02% in the period of the last 30 days. Common stock shares were driven by 12.73% during last recorded quarter.